Higher Doses of Sponsor Drugs Given in Anti-Depressant Trials
Higher Doses of Sponsor Drugs Given in Anti-Depressant Trials
About this item
Full title
Higher Doses of Sponsor Drugs Given in Anti-Depressant Trials
Publisher
Toronto: Intrado Digital Media Canada Inc
Journal title
Marketwire, 2012-03
Language
English
Formats
Publication information
Publisher
Toronto: Intrado Digital Media Canada Inc
Subjects
More information
Scope and Contents
Contents
"After examining the doses administered in 58 trials, we found that in 37% of those trials, the sponsor medication dose was higher, while in only 5% of trials, the nonsponsor medication dose was higher," says Dr. Mark Sinyor, Co-Chief Resident, Psychiatry, Sunnybrook Health Sciences Centre and lead author of the study. The team identified several p...
Alternative Titles
Full title
Higher Doses of Sponsor Drugs Given in Anti-Depressant Trials
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_reports_927853308
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_reports_927853308
How to access this item
Log in as a Library member
